174 related articles for article (PubMed ID: 21865090)
1. Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX.
Kasow KA; Morales-Tirado VM; Wichlan D; Shurtleff SA; Abraham A; Persons DA; Riberdy JM
Clin Immunol; 2011 Nov; 141(2):169-76. PubMed ID: 21865090
[TBL] [Abstract][Full Text] [Related]
2. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.
Rao A; Kamani N; Filipovich A; Lee SM; Davies SM; Dalal J; Shenoy S
Blood; 2007 Jan; 109(1):383-5. PubMed ID: 16990602
[TBL] [Abstract][Full Text] [Related]
3. FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.
Dorsey MJ; Petrovic A; Morrow MR; Dishaw LJ; Sleasman JW
Immunol Res; 2009; 44(1-3):179-84. PubMed ID: 19471859
[TBL] [Abstract][Full Text] [Related]
4. Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Burroughs LM; Torgerson TR; Storb R; Carpenter PA; Rawlings DJ; Sanders J; Scharenberg AM; Skoda-Smith S; Englund J; Ochs HD; Woolfrey AE
J Allergy Clin Immunol; 2010 Nov; 126(5):1000-5. PubMed ID: 20643476
[TBL] [Abstract][Full Text] [Related]
5. Successful Salvage Haploidentical Alpha-Beta T Cell-Depleted Stem Cell Transplantation After Busulfan-Based Myeloablation in a Patient With IPEX Syndrome: A Case Report.
Martuszewski A; Paluszkiewicz P; Wawrzyniak-Dzierżek E; Drożyńska-Duklas M; Bąbol-Pokora K; Myśliwiec M; Szymczak D; Irga-Jaworska N; Młynarski W; Kałwak K; Ussowicz M
Transplant Proc; 2019 Nov; 51(9):3150-3154. PubMed ID: 31611124
[TBL] [Abstract][Full Text] [Related]
6. IPEX due to an exon 7 skipping FOXP3 mutation with autoimmune diabetes mellitus cured by selective T
Magg T; Wiebking V; Conca R; Krebs S; Arens S; Schmid I; Klein C; Albert MH; Hauck F
Clin Immunol; 2018 Jun; 191():52-58. PubMed ID: 29567430
[TBL] [Abstract][Full Text] [Related]
7. Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells.
McMurchy AN; Gillies J; Allan SE; Passerini L; Gambineri E; Roncarolo MG; Bacchetta R; Levings MK
J Allergy Clin Immunol; 2010 Dec; 126(6):1242-51. PubMed ID: 21036387
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome.
Zhan H; Sinclair J; Adams S; Cale CM; Murch S; Perroni L; Davies G; Amrolia P; Qasim W
Pediatrics; 2008 Apr; 121(4):e998-1002. PubMed ID: 18316354
[TBL] [Abstract][Full Text] [Related]
9. Proteomics plus genomics approaches in primary immunodeficiency: the case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.
Zennaro D; Scala E; Pomponi D; Caprini E; Arcelli D; Gambineri E; Russo G; Mari A
Clin Exp Immunol; 2012 Jan; 167(1):120-8. PubMed ID: 22132891
[TBL] [Abstract][Full Text] [Related]
10. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases.
Verbsky JW; Chatila TA
Curr Opin Pediatr; 2013 Dec; 25(6):708-14. PubMed ID: 24240290
[TBL] [Abstract][Full Text] [Related]
11. Identification of FOXP3-negative regulatory T-like (CD4(+)CD25(+)CD127(low)) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Otsubo K; Kanegane H; Kamachi Y; Kobayashi I; Tsuge I; Imaizumi M; Sasahara Y; Hayakawa A; Nozu K; Iijima K; Ito S; Horikawa R; Nagai Y; Takatsu K; Mori H; Ochs HD; Miyawaki T
Clin Immunol; 2011 Oct; 141(1):111-20. PubMed ID: 21802372
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
13. Selective expansion of donor-derived regulatory T cells after allogeneic bone marrow transplantation in a patient with IPEX syndrome.
Horino S; Sasahara Y; Sato M; Niizuma H; Kumaki S; Abukawa D; Sato A; Imaizumi M; Kanegane H; Kamachi Y; Sasaki S; Terui K; Ito E; Kobayashi I; Ariga T; Tsuchiya S; Kure S
Pediatr Transplant; 2014 Feb; 18(1):E25-30. PubMed ID: 24224516
[TBL] [Abstract][Full Text] [Related]
14. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients.
Passerini L; Barzaghi F; Curto R; Sartirana C; Barera G; Tucci F; Albarello L; Mariani A; Testoni PA; Bazzigaluppi E; Bosi E; Lampasona V; Neth O; Zama D; Hoenig M; Schulz A; Seidel MG; Rabbone I; Olek S; Roncarolo MG; Cicalese MP; Aiuti A; Bacchetta R
J Allergy Clin Immunol; 2020 Apr; 145(4):1262-1271.e13. PubMed ID: 31874182
[TBL] [Abstract][Full Text] [Related]
15. Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
Bacchetta R; Passerini L; Gambineri E; Dai M; Allan SE; Perroni L; Dagna-Bricarelli F; Sartirana C; Matthes-Martin S; Lawitschka A; Azzari C; Ziegler SF; Levings MK; Roncarolo MG
J Clin Invest; 2006 Jun; 116(6):1713-22. PubMed ID: 16741580
[TBL] [Abstract][Full Text] [Related]
16. Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.
Passerini L; Di Nunzio S; Gregori S; Gambineri E; Cecconi M; Seidel MG; Cazzola G; Perroni L; Tommasini A; Vignola S; Guidi L; Roncarolo MG; Bacchetta R
Eur J Immunol; 2011 Apr; 41(4):1120-31. PubMed ID: 21400500
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral Gene Therapy in HSCs Restores Lineage-Specific Foxp3 Expression and Suppresses Autoimmunity in a Mouse Model of IPEX Syndrome.
Masiuk KE; Laborada J; Roncarolo MG; Hollis RP; Kohn DB
Cell Stem Cell; 2019 Feb; 24(2):309-317.e7. PubMed ID: 30639036
[TBL] [Abstract][Full Text] [Related]
18. Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome.
Barzaghi F; Passerini L; Gambineri E; Ciullini Mannurita S; Cornu T; Kang ES; Choe YH; Cancrini C; Corrente S; Ciccocioppo R; Cecconi M; Zuin G; Discepolo V; Sartirana C; Schmidtko J; Ikinciogullari A; Ambrosi A; Roncarolo MG; Olek S; Bacchetta R
J Autoimmun; 2012 Feb; 38(1):49-58. PubMed ID: 22264504
[TBL] [Abstract][Full Text] [Related]
19. CD4⁺ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer.
Passerini L; Rossi Mel E; Sartirana C; Fousteri G; Bondanza A; Naldini L; Roncarolo MG; Bacchetta R
Sci Transl Med; 2013 Dec; 5(215):215ra174. PubMed ID: 24337481
[TBL] [Abstract][Full Text] [Related]
20. Successful Allogeneic Hematopoietic Stem Cell Transplantation in XIAP Deficiency Using Reduced-Intensity Conditioning.
Chellapandian D; Krueger J; Schechter T; Gassas A; Weitzman S; Naqvi A; Ali M
Pediatr Blood Cancer; 2016 Feb; 63(2):355-7. PubMed ID: 26398727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
